Skip navigation
Please use this identifier to cite or link to this item: https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/650
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLaw, L. Y.-
dc.contributor.authorTan, I.-
dc.contributor.authorProwse, M.-
dc.contributor.authorRiminton, D. S.-
dc.contributor.authorReddel, S. W.-
dc.date.accessioned2025-06-05T04:30:59Z-
dc.date.available2025-06-05T04:30:59Z-
dc.date.issued2019-09-
dc.identifier.citationJournal of Clinical Neuroscience. 2019 Sep:67:261-263en
dc.identifier.urihttps://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/650-
dc.description.abstractA case of progressive multifocal leukoencephalopathy (PML) occurring on low dose immunosuppression for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS) is presented. Neurologic changes in patients with SLE or SS should not be assumed to be a disease manifestation. Importantly, serious opportunistic infections such as PML can occur in minimally immunosuppressed rheumatic patients. Early diagnosis, facilitated by scrutiny of MRI findings, should trigger measures to reconstitute immunity in an otherwise fatal disease.en
dc.language.isoenen
dc.subjectLeukoencephalopathy, Progressive Multifocalen
dc.subjectImmunosuppression Therapyen
dc.subjectLupus Erythematosus, Systemicen
dc.subjectEarly Diagnosisen
dc.titleProgressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus: Clues to early diagnosisen
dc.typeArticleen
dc.contributor.mnclhdauthorProwse, Michael V.-
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/31278051en
dc.identifier.doi10.1016/j.jocn.2019.06.030en
Appears in Collections:Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing